Risk Time Period

10 years

Age

50 years
Gender MaleFemale
Race BlackNon-Black
Smoker YesNo

CVD risk is reversed after 5-10 years of no smoking

Diabetes YesNo

Systolic Blood Pressure

120 mmHg

120 mmHg is used for baseline risk

On treatment for BP YesNo

Only applies if SBP is greater than 120 mmHg

Total Cholesterol

3 mmol/L
116 mg/dL

3 mmol/L is used for baseline risk.
Click to change to mg/dL.

116 mg/dL is used for baseline risk.
Click to change to mmol/L.

HDL Cholesterol

1.3 mmol/L
50 mg/dL

1.3 mmol/L is used for baseline risk.

50 mg/dL is used for baseline risk.

Relative Benefit:  0%

Benefit often has nothing to do with the effect on the surrogate marker. At present, you can only select one intervention at a time.

  • Physical Activity
  • Mediterranean Diet vs Low fat
  • Vitamin/Omega-3 supplements
  • BP meds (not atenolol/doxazosin)
  • Statins
  • Fibrates
  • Niacin
  • Ezetimibe
  • Metformin
  • Sulfonylureas
  • Insulins
  • Glitazones
  • GLPs
  • DPP-4s
  • Meglitinides
  • ASA
Benefit Estimate Details

Family History of Early CHD

If CHD in men < 55 years, women < 65 years - increase risk by 50%. If no family history - decrease estimates by 33%.

Adjust Overall Risk

100 %

Use to adjust risk based on family history or if patient is at a lower/higher risk than the Framingham cohort. See the FAQ for guidance.

No events
Baseline events using baseline factors
Additional events – “caused” by risk factors over baseline
Benefits – will not have an event because of “treatment”
NNT % Number needed to treat

As with all risk calculators, calculated risk numbers are +/- 5% at best. More information.